Workflow
瑞丰高材(300243) - 2022 Q1 - 季度财报
RUIFENG CHEMRUIFENG CHEM(SZ:300243)2022-04-25 16:00

Revenue and Profit - Revenue for Q1 2022 reached ¥501,228,023.58, an increase of 26.04% compared to ¥397,688,837.01 in the same period last year[5] - Net profit attributable to shareholders was ¥31,394,431.21, a slight increase of 0.46% from ¥31,250,331.68 year-on-year[5] - Operating profit for the current period was ¥36,659,936.81, slightly up from ¥35,692,333.37, reflecting a growth of 2.7%[21] - Net profit for the current period was ¥31,394,431.21, compared to ¥30,690,072.27 in the previous period, indicating a growth of 2.3%[21] Cash Flow and Liquidity - Net cash flow from operating activities was -¥90,964,610.07, a decrease of 69.57% compared to -¥53,643,922.46 in the previous year[10] - Cash flow from operating activities showed a net outflow of ¥90,964,610.07, worsening from a net outflow of ¥53,643,922.46 in the prior period[26] - Cash and cash equivalents decreased to CNY 122,089,846.92 from CNY 233,330,940.31, representing a decline of approximately 47.7%[16] - Cash and cash equivalents at the end of the period totaled ¥110,338,912.77, compared to ¥76,381,701.66 at the end of the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,727,646,706.14, reflecting a 2.33% increase from ¥1,688,335,544.59 at the end of the previous year[5] - Current assets totaled CNY 882,804,441.51, slightly up from CNY 874,825,501.27, indicating a growth of about 0.11%[16] - Total liabilities stood at CNY 799,303,501.88, a slight increase from CNY 794,297,131.08, reflecting a growth of about 0.64%[18] - The company’s long-term borrowings increased by 40.93% to ¥169,400,000.00 from ¥120,200,000.00 at the beginning of the period[9] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,335, with the largest shareholder holding 22.28% of the shares[11] - The total equity attributable to shareholders increased by 3.84% to ¥928,343,204.26 from ¥894,038,413.51 at the end of the previous year[6] - The company reported a total of 43,455,519 shares under lock-up agreements, with no changes during the period[13] Expenses - Research and development expenses decreased by 69.19% to ¥866,834.70 from ¥2,813,347.35 in the previous year[10] - The company reported a 53.24% increase in sales expenses, totaling ¥30,928,946.84, due to higher shipping volumes and increased market development costs[9] - The company incurred financial expenses of ¥4,425,646.49, which increased from ¥2,707,231.39, reflecting a rise of 63.5%[21] Earnings Per Share - The company's basic earnings per share remained unchanged at ¥0.14, while diluted earnings per share also stayed at ¥0.13[5] - Basic earnings per share remained stable at ¥0.14, consistent with the previous period[22]